Performance of SAGE Sage Therapeutic | -72.5% in 12m

Compare SAGE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Sage Therapeutic with its related Sector/Index XBI

Compare Sage Therapeutic with its related Sector/Index XBI

Performance Duell SAGE vs XBI

TimeFrame SAGE XBI
1 Day -19.6% -1.12%
1 Week -23.6% -5.89%
1 Month -35.1% -8.93%
3 Months -53.4% -4.18%
6 Months -36.0% 20.43%
12 Months -72.5% 3.47%
YTD -44.1% -6.18%
Rel. Perf. 1m -2.43
Rel. Perf. 3m -4.64
Rel. Perf. 6m -5.27
Rel. Perf. 12m -12.49

Is Sage Therapeutic a good stock to buy?

No, based on ValueRay Fundamental Analyses, Sage Therapeutic (NASDAQ:SAGE) is currently (April 2024) a stock to sell. It has a ValueRay Fundamental Rating of -6.51 and therefor a negative outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAGE as of April 2024 is 8.54. This means that SAGE is currently overvalued and has a potential downside of -32.06%.

Is SAGE a buy, sell or hold?

  • Strong Buy: 1
  • Buy: 3
  • Hold: 17
  • Sell: 0
  • Strong Sell: 0
Sage Therapeutic has received a consensus analysts rating of 3.24. Therefor, it is recommend to hold SAGE.
Values above 0%: SAGE is performing better - Values below 0%: SAGE is underperforming

Compare SAGE with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -20.95% -32.71% -51.62% -95.21%
US NASDAQ 100 QQQ -20.73% -32.45% -52.10% -106.99%
US Dow Jones Industrial 30 DIA -21.75% -32.46% -48.06% -85.73%
German DAX 40 DBXD -21.74% -34.18% -52.37% -84.49%
UK FTSE 100 ISFU -21.73% -34.96% -42.25% -76.77%
Shanghai Shenzhen CSI 300 CSI 300 -25.73% -33.34% -34.63% -55.20%
Hongkong Hang Seng HSI -17.62% -25.82% -22.53% -45.15%
Japan Nikkei 225 EXX7 -19.76% -29.66% -49.51% -90.92%
India NIFTY 50 INDA -21.20% -35.64% -49.85% -100.14%
Brasil Bovespa EWZ -17.64% -29.42% -37.96% -82.13%

SAGE Sage Therapeutic vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -21.14% -34.19% -53.52% -109.58%
Consumer Discretionary XLY -20.08% -31.37% -42.85% -89.93%
Consumer Staples XLP -22.34% -32.35% -45.89% -72.36%
Energy XLE -19.85% -38.39% -41.13% -85.52%
Financial XLF -20.66% -32.22% -54.73% -94.00%
Health Care XLV -21.37% -30.70% -42.54% -77.19%
Industrial XLI -21.19% -34.48% -54.42% -94.92%
Materials XLB -20.74% -33.30% -49.61% -84.12%
Real Estate XLRE -18.64% -27.27% -41.35% -71.40%
Technology XLK -20.73% -31.50% -53.80% -106.91%
Utilities XLU -22.45% -36.45% -45.15% -68.23%
Aerospace & Defense XAR -21.41% -32.01% -48.85% -86.68%
Biotech XBI -17.70% -26.18% -56.43% -76.01%
Homebuilder XHB -20.14% -31.39% -70.16% -122.47%
Retail XRT -19.91% -28.80% -52.11% -87.23%

SAGE Sage Therapeutic vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -19.72% -36.30% -36.14% -83.93%
Natural Gas UNG -15.36% -28.85% 13.93% -22.96%
Gold GLD -25.44% -44.89% -59.16% -90.90%
Silver SLV -25.16% -47.94% -59.57% -84.83%
Copper CPER -25.27% -40.66% -58.48% -81.56%

Returns of SAGE vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -22.55% -31.79% -42.79% -61.71%
iShares High Yield Corp. Bond HYG -22.67% -33.71% -43.94% -79.69%
Does Sage Therapeutic outperform its market, is SAGE a Sector Leader?
No, over the last 12 months Sage Therapeutic (SAGE) made -72.54%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.47%.
Over the last 3 months SAGE made -53.36%, while XBI made -4.18%.
Period SAGE XBI S&P 500
1 Month -35.11% -8.93% -2.40%
3 Months -53.36% -4.18% 6.31%
12 Months -72.54% 3.47% 22.67%